Physician profile
Edward Distler
NPI 1891180352
$25,641.29
in general payments reported to CMS, 2019-2025
35 companies · $1,849 in 2025
The $1,849 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $804 · 2020: $820 · 2021: $16K · 2022: $1,895 · 2023: $1,003 · 2024: $3,062 · 2025: $1,849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,931 · Travel and Lodging: $984.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,930.55 |
| Travel and Lodging | $983.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16,360.88 | 2021-2025 | Symplicity G3, Corevalve Evolut R, Reveal Linq |
| Abiomed | $1,566.48 | 2020-2025 | Impella |
| Shockwave Medical, INC | $960.54 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $709.15 | 2022-2025 | Camzyos, Eliquis |
| Amgen INC. | $635.49 | 2020-2025 | Repatha, Repatha |
| Abbott Laboratories | $523.07 | 2019-2025 | Mitraclip, Navitor |
| Novartis Pharmaceuticals Corporation | $509.20 | 2023-2025 | |
| Medtronic Vascular, INC. | $502.31 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $464.69 | 2022-2025 | Jardiance |
| Boston Scientific Corporation | $413.06 | 2019-2025 | Watchman Flx, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Merck Sharp & Dohme LLC | $380.10 | 2022-2025 | Verquvo, Capvaxive |
| Janssen Pharmaceuticals, INC | $332.50 | 2022-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $266.77 | 2020-2025 | Farxiga, Wainua, Lokelma |
| Pfizer INC. | $242.33 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $212.38 | 2019-2025 | Lifevest |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $207.91 | 2019-2022 | |
| Livanova USA, INC. | $156.34 | 2021 | |
| Philips North America LLC | $144.98 | 2022-2025 | Coronary Other |
| Cvrx, INC. | $137.78 | 2022 | |
| Terumo Medical Corporation | $134.24 | 2022 | |
| Cardiovascular Systems INC. | $96.56 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $96.45 | 2022 | |
| Alnylam Pharmaceuticals INC. | $91.57 | 2022-2025 | Amvuttra |
| Daiichi Sankyo INC. | $91.03 | 2023-2024 | Injectafer |
| Bridgebio Pharma, INC. | $62.20 | 2025 | Attruby |
| Atricure, INC. | $54.85 | 2022-2023 | |
| Kestra Medical Technology Services, INC. | $52.53 | 2025 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $50.54 | 2025 | |
| Biosense Webster, INC. | $45.72 | 2019-2020 | |
| Lantheus Medical Imaging, INC. | $41.57 | 2022-2023 | Definity |
| Edwards Lifesciences Corporation | $35.05 | 2024 | Pascal |
| Getinge USA Sales, LLC | $20.33 | 2021 | |
| Chiesi USA, INC. | $15.23 | 2025 | Kengreal |
| Lilly USA, LLC | $13.81 | 2025 | Mounjaro, Zepbound |
| Asahi Intecc USA, INC. | $13.65 | 2024 | Peripheral Vascular |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Distler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.